154 related articles for article (PubMed ID: 7032925)
1. Adjuvant chemotherapy with chlorambucil and 5-fluorouracil in primary breast cancer (Cooperative Study Heidelberg).
Kaufmann M; Fournier DV; Sievers H; Staib I; Wöllgens P; Nedden R; Lochbühler H; Queisser W; Christmann D; Bühner R; Pfuhl PJ; Henningsen B; Kuttig H; Wysocki S; Thüre D; Köhler C; Drings P
Eur J Cancer (1965); 1980; Suppl 1():157-60. PubMed ID: 7032925
[No Abstract] [Full Text] [Related]
2. Divergent effect of adjuvant chemo-immunotherapy on recurrence rates in node-negative and node-positive breast cancer patients.
Jungi WF; Senn HJ; Amgwerd R; Hochuli E
Eur J Cancer (1965); 1980; Suppl 1():169-72. PubMed ID: 7032928
[No Abstract] [Full Text] [Related]
3. Hormono-chemotherapy versus hormonotherapy followed by chemotherapy in the treatment of disseminated breast cancer.
Cavalli F; Alberto P; Jungi F; Brunner K; Martz G
Eur J Cancer (1965); 1980; Suppl 1():125-9. PubMed ID: 7032922
[No Abstract] [Full Text] [Related]
4. Adjuvant chemotherapy with four drugs for stage 2 breast cancer.
Wheeler TK; Edelstyn GA; Bates TS; Brinkley D; Evans RG; Kitchen G; MacRae KD; Nicol NT; Spittle M; Wheeler TK
Eur J Cancer (1965); 1980; Suppl 1():161-3. PubMed ID: 7032926
[No Abstract] [Full Text] [Related]
5. Adjuvant chemotherapy, anti-estrogen therapy and immunotherapy for stage II breast cancer.
Hubay CA; Pearson OH; Marshall JS; Rhodes RS; Debanne SM; Mansour EG; Hermann RE; Jones JC; Flynn WJ; Eckert C; McGuire WL
Eur J Cancer (1965); 1980; Suppl 1():189-95. PubMed ID: 7032932
[No Abstract] [Full Text] [Related]
6. [Adjuvant chemotherapy of breast neoplasms. Review of the up-to-date results of various studies including the Heidelberg study].
Queisser W
Fortschr Med; 1980 Feb; 98(8):286-8. PubMed ID: 7380378
[No Abstract] [Full Text] [Related]
7. A phase III study of prednimustine (LEO 1031) in advanced breast cancer. A preliminary report.
Rørth M; Løber J; Dombernowsky P; Krusenstjerna-Hofstrom D; Mattsson W; Mouridsen HT
Eur J Cancer (1965); 1980; Suppl 1():137-40. PubMed ID: 7032923
[No Abstract] [Full Text] [Related]
8. Surgical adjuvant trials in the United States.
Rozencweig M; Von Hoff DD; Allegra JC; Muggia FM
Eur J Cancer (1965); 1980; Suppl 1():173-7. PubMed ID: 7032929
[No Abstract] [Full Text] [Related]
9. Trials of adjuvant chemotherapy in breast cancer. The experience of the Istituto Nazionale Tumori of Milan.
Rossi A; Bonadonna G; Tancini G; Bajetta E; Marchini S; Valagussa P; Veronesi U
Eur J Cancer (1965); 1980; Suppl 1():149-56. PubMed ID: 7032924
[No Abstract] [Full Text] [Related]
10. Significance of relapse after adjuvant treatment with combination chemotherapy or 5-fluorouracil alone in high-risk breast cancer. A Western Cancer Study Group Project.
Chlebowski RT; Weiner JM; Luce J; Hestorff R; Lang JE; Reynolds R; Godfrey T; Ryden VM; Bateman JR
Cancer Res; 1981 Nov; 41(11 Pt 1):4399-403. PubMed ID: 7306966
[TBL] [Abstract][Full Text] [Related]
11. [Preliminary results of a continuous study protocol with adjuvant chemotherapy in primary operable breast carcinoma].
Cavalli F; Jungi F; Alberto P; Martz G; Brunner KW
Haematol Blood Transfus; 1978; 22():61-6. PubMed ID: 374200
[No Abstract] [Full Text] [Related]
12. [Internal cancer therapy: cooperative clinical studies. Principles, organization and first results of the Swiss chemotherapy group].
Praxis; 1967 Dec; 56(50):1691-5. PubMed ID: 5632569
[No Abstract] [Full Text] [Related]
13. Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.
Weiss RB; Woolf SH; Demakos E; Holland JF; Berry DA; Falkson G; Cirrincione CT; Robbins A; Bothun S; Henderson IC; Norton L;
J Clin Oncol; 2003 May; 21(9):1825-35. PubMed ID: 12721260
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemoimmunotherapy with LMF + BCG in node-negative and node-positive breast cancer patients. Intermediate report of a randomized trial in 242 patients.
Senn HJ; Jungi WF; Amgwerd R; Sprenger F; Hochueli R; Engelhart G; Heinz C; Wick A; Enderlin F; Creux G; Simeon B; Lanz R; Bigler R
Antibiot Chemother (1971); 1978; 24():213-28. PubMed ID: 350137
[No Abstract] [Full Text] [Related]
15. Variations in responsiveness and survival of clinical subsets of patients with metastatic breast cancer to two chemotherapy combinations.
Smalley RV; Bartolucci AA
Eur J Cancer (1965); 1980; Suppl 1():141-6. PubMed ID: 7318861
[No Abstract] [Full Text] [Related]
16. [Radiation and concomitant chemotherapy after surgery for breast cancer].
Calais G
Cancer Radiother; 2004 Feb; 8(1):39-47. PubMed ID: 15093200
[TBL] [Abstract][Full Text] [Related]
17. [Adjuvant endocrine therapy and chemotherapy of breast cancer (author's transl)].
Heuson JC; Paridaens R
Rev Med Brux; 1982 Apr; 3(4):209-16. PubMed ID: 7046007
[No Abstract] [Full Text] [Related]
18. [Chemotherapy of advanced prostate cancer].
Murphy GP
Vopr Onkol; 1977; 23(12):26-38. PubMed ID: 146305
[No Abstract] [Full Text] [Related]
19. [Recent advance in adjuvant therapy for breast cancer].
Shimizu C; Watanabe T
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2458-69. PubMed ID: 12506467
[TBL] [Abstract][Full Text] [Related]
20. [Adjuvant (preventive) postoperative chemotherapy in breast carcinoma].
Kaufmann M; Kubli F; Drings P; Lammers G
Dtsch Med Wochenschr; 1978 Nov; 103(47):1881-7. PubMed ID: 361367
[No Abstract] [Full Text] [Related]
[Next] [New Search]
